- Home
- USLM vs RCKT Comparison
USLM vs RCKT Comparison
Compare USLM & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | USLM | RCKT |
|---|---|---|
| Founded | 1948 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 340.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | USLM | RCKT |
|---|---|---|
| Price | $127.25 | $3.51 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $29.12 |
| AVG Volume (30 Days) | 74.6K | ★ 2.0M |
| Earning Date | 02-02-2026 | 11-06-2025 |
| Dividend Yield | ★ 0.19% | N/A |
| EPS Growth | ★ 32.23 | N/A |
| EPS | ★ 4.55 | N/A |
| Revenue | ★ $364,849,000.00 | N/A |
| Revenue This Year | $22.64 | N/A |
| Revenue Next Year | $8.38 | N/A |
| P/E Ratio | $27.97 | ★ N/A |
| Revenue Growth | ★ 20.27 | N/A |
| 52 Week Low | $80.47 | $2.19 |
| 52 Week High | $138.51 | $13.35 |
Technical Indicators
Market Signals| Indicator | USLM | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 55.92 | 55.18 |
| Support Level | $123.45 | $3.19 |
| Resistance Level | $131.38 | $3.60 |
| Average True Range (ATR) | 3.99 | 0.20 |
| MACD | 0.44 | 0.02 |
| Stochastic Oscillator | 58.66 | 69.57 |
Price Performance
Historical ComparisonAbout USLM United States Lime & Minerals Inc.
United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.